Physician

Brian Jeffrey Feinstein, D.O.

According to 2025 Medicare claims, Brian Feinstein, D.O. (NPI: 1780802595) practices dermatology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is FEINSTEIN MEDICAL LLC (NPI: 1548416068; TIN: 261637814) and primary practice location at 33484-8409.

Feinstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,090 traditional Medicare patients, billed 25,162 HCPCS/CPT codes, and received $3,113,686 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 2,451 prescription claims across 1,062 beneficiaries totaling $151,780 in drug costs, led by Dupixent Pen (Dupilumab). 2021 DME data shows 157 claims. Open Payments data shows 239 records totaling $1,290,604. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,526,742 to $3,113,686. In contrast, Part D prescription costs have declined steadily, from $233,372 to $151,780. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,285	18,641	$1,526,742
2016	1,458	17,204	$1,408,246
2017	1,512	15,069	$1,281,434
2018	1,663	17,312	$1,559,313
2019	1,997	23,569	$2,111,266
2020	1,781	20,949	$1,703,809
2021	1,722	19,084	$1,628,995
2022	1,911	22,054	$2,092,800
2023	2,051	23,245	$2,214,685
2024	2,090	25,162	$3,113,686

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	727	2,120	$233,372
2016	740	2,088	$201,589
2017	841	2,305	$197,859
2018	840	1,848	$255,960
2019	1,033	2,372	$245,600
2020	969	2,258	$140,932
2021	872	1,930	$179,231
2022	950	2,095	$128,909
2023	1,016	2,304	$152,220
2024	1,062	2,451	$151,780

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	64	82	$33,339
2019	261	328	$159,269
2020	258	288	$128,503
2021	138	157	$55,786
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	1,458	2,290	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,627	3,062	$72
11103	Biopsy of related skin growth, each additional growth	879	2,004	$43
17000	Destruction of precancer skin growth, 1 growth	1,199	2,189	$38
17003	Destruction of precancer skin growth, 2-14 growths	832	4,552	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	13	462	$62,256
Mupirocin	Mupirocin	746	14,151	$4,603
Doxycycline Hyclate	Doxycycline Hyclate	463	5,500	$4,128
Ketoconazole	Ketoconazole	240	7,261	$3,449
Gentamicin Sulfate	Gentamicin Sulfate	85	2,040	$3,276

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$632	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	210	$1,289,972	SANOFI US SERVICES INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Jeffrey Feinstein, D.O.?

Tedicare shows public-source Medicare data for Brian Jeffrey Feinstein, D.O. (NPI 1780802595), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Jeffrey Feinstein, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian Jeffrey Feinstein, D.O.?

Brian Jeffrey Feinstein, D.O. is linked to FEINSTEIN MEDICAL LLC (billing NPI 1548416068) in the available physician profile data.

Does Brian Jeffrey Feinstein, D.O. have Open Payments data?

Brian Jeffrey Feinstein, D.O. has 239 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.